Groman Dan

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 21% 68% 82%
Transactions
9 11% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Groman Dan's trades of Savills PLC's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-16 2026-03-13
GB Savills PLC (SVS)
B Purchase
72,693
105.64
£3,871,302 		72,693 105.64 £3,871,302
2024-02-16 2024-02-16
US Enfusion Inc (ENFN)
PrS Proposed sale
84,559
491.49
US$3,086,011 		84,559 491.49 US$3,086,011
2024-02-15 2024-02-15
US Enfusion Inc (ENFN)
PrS Proposed sale
94,039
458.10
US$4,565,349 		94,039 458.10 US$4,565,349
2024-01-24 2024-01-24
US Enfusion Inc (ENFN)
PrS Proposed sale
14
9.03
US$126 		14 9.03 US$126
2024-01-23 2024-01-23
US Enfusion Inc (ENFN)
PrS Proposed sale
101
9.00
US$909 		101 9.00 US$909
2024-01-22 2024-01-22
US Enfusion Inc (ENFN)
PrS Proposed sale
4,615
9.01
US$41,564 		4,615 9.01 US$41,564
2024-01-09 2024-01-09
US Enfusion Inc (ENFN)
PrS Proposed sale
340
8.95
US$3,043 		340 8.95 US$3,043
2024-01-08 2024-01-08
US Enfusion Inc (ENFN)
PrS Proposed sale
325
9.23
US$3,001 		325 9.23 US$3,001
2023-12-14 2023-12-14
US Enfusion Inc (ENFN)
PrS Proposed sale
5,000
10.10
US$50,500 		5,000 10.10 US$50,500
2023-11-16 2023-11-14
US Enfusion Inc (ENFN)
PlS Planned sale
5,000 -3.6%
9.97
US$49,850 		5,000 -3.6% 9.97 US$49,850
2023-11-14 2023-11-14
US Enfusion Inc (ENFN)
PrS Proposed sale
5,000
9.97
US$49,854 		5,000 9.97 US$49,854
2023-10-19 2023-10-17
US Enfusion Inc (ENFN)
PlS Planned sale
5,000 -3.5%
9.09
US$45,450 		5,000 -3.5% 9.09 US$45,450
2023-10-17 2023-10-17
US Enfusion Inc (ENFN)
PrS Proposed sale
5,000
9.09
US$45,462 		5,000 9.09 US$45,462
2023-09-21 2023-09-19
US Enfusion Inc (ENFN)
PlS Planned sale
5,000 -3.4%
9.07
US$45,350 		5,000 -3.4% 9.07 US$45,350
2023-09-19 2023-09-19
US Enfusion Inc (ENFN)
PrS Proposed sale
5,000
9.07
US$45,330 		5,000 9.07 US$45,330
2023-08-15 2023-08-14
US Enfusion Inc (ENFN)
S Sale
1,760 -1.5%
7.89
US$13,886 		1,760 -1.5% 7.89 US$13,886
2023-08-14 2023-08-14
US Enfusion Inc (ENFN)
PrS Proposed sale
1,760
7.89
US$13,890 		1,760 7.89 US$13,890
2023-08-14 2023-08-11
US Enfusion Inc (ENFN)
S Sale
1,850 -1.6%
8.10
US$14,985 		1,850 -1.6% 8.10 US$14,985
2023-08-11 2023-08-11
US Enfusion Inc (ENFN)
PrS Proposed sale
1,850
8.10
US$14,978 		1,850 8.10 US$14,978
2023-08-11 2023-08-10
US Enfusion Inc (ENFN)
S Sale
2,106 -1.8%
8.08
US$17,016 		2,106 -1.8% 8.08 US$17,016
2023-08-10 2023-08-10
US Enfusion Inc (ENFN)
PrS Proposed sale
2,106
8.08
US$17,011 		2,106 8.08 US$17,011
2023-08-10 2023-08-09
US Enfusion Inc (ENFN)
S Sale
2,317 -2.0%
8.32
US$19,277 		2,317 -2.0% 8.32 US$19,277
2023-08-09 2023-08-09
US Enfusion Inc (ENFN)
PrS Proposed sale
2,317
8.32
US$19,267 		2,317 8.32 US$19,267
2023-07-19 2023-07-17
US Enfusion Inc (ENFN)
PlS Planned sale
3,877 -3.4%
11.31
US$43,849 		3,877 -3.4% 11.31 US$43,849
2023-07-17 2023-07-17
US Enfusion Inc (ENFN)
PrS Proposed sale
3,877
11.31
US$43,849 		3,877 11.31 US$43,849
2023-06-22 2023-06-20
US Enfusion Inc (ENFN)
PlS Planned sale
3,877 -3.3%
8.86
US$34,350 		3,877 -3.3% 8.86 US$34,350
2023-06-20 2023-06-20
US Enfusion Inc (ENFN)
PrS Proposed sale
3,877
8.86
US$34,350 		3,877 8.86 US$34,350
2023-05-24 2023-05-22
US Enfusion Inc (ENFN)
S Sale
50,000 -65.8%
7.91
US$395,500 		50,000 -65.8% 7.91 US$395,500
2023-05-24 2023-05-22
US Enfusion Inc (ENFN)
PlS Planned sale
3,877 -4.9%
8.00
US$31,016 		3,877 -4.9% 8.00 US$31,016
2023-05-22 2023-05-22
US Enfusion Inc (ENFN)
PrS Proposed sale
3,877
8.00
US$31,016 		3,877 8.00 US$31,016
2023-05-22 2023-05-22
US Enfusion Inc (ENFN)
PrS Proposed sale
50,000
7.91
US$395,253 		50,000 7.91 US$395,253
2023-05-12 2023-05-10
US Enfusion Inc (ENFN)
S Sale
15,048 -15.9%
8.34
US$125,500 		15,048 -15.9% 8.34 US$125,500
2023-05-10 2023-05-10
US Enfusion Inc (ENFN)
PrS Proposed sale
15,048
8.34
US$125,514 		15,048 8.34 US$125,514
2023-04-19 2023-04-17
US Enfusion Inc (ENFN)
PlS Planned sale
3,877 -4.5%
9.66
US$37,452 		3,877 -4.5% 9.66 US$37,452
2023-04-17 2023-04-17
US Enfusion Inc (ENFN)
PrS Proposed sale
3,877
9.66
US$37,452 		3,877 9.66 US$37,452
2023-03-21 2023-03-17
US Enfusion Inc (ENFN)
PlS Planned sale
3,877 -4.3%
10.94
US$42,414 		3,877 -4.3% 10.94 US$42,414
2023-03-17 2023-03-17
US Enfusion Inc (ENFN)
PrS Proposed sale
3,877
10.94
US$42,414 		3,877 10.94 US$42,414
2023-02-22 2023-02-17
US Enfusion Inc (ENFN)
PlS Planned sale
3,877 -4.1%
10.93
US$42,376 		3,877 -4.1% 10.93 US$42,376
2023-01-19 2023-01-17
US Enfusion Inc (ENFN)
PlS Planned sale
3,877 -4.6%
10.93
US$42,376 		3,877 -4.6% 10.93 US$42,376
2022-11-16 2022-11-15
US Enfusion Inc (ENFN)
S Sale
5,103 -4.4%
14.06
US$71,748 		5,103 -4.4% 14.06 US$71,748
2022-11-16 2022-11-14
US Enfusion Inc (ENFN)
S Sale
7,000 -5.7%
13.69
US$95,830 		7,000 -5.7% 13.69 US$95,830